Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has The Prenatal And Newborn Genetic Testing Market Size Shifted, And What Is the Outlook Through 2034?
In recent times, the scale of the prenatal and newborn genetic testing market has been expanding swiftly. Its size is anticipated to rise from $6.68 billion in 2024 to reach $7.6 billion in 2025, boasting a compound annual growth rate (CAGR) of 13.7%. The expansion witnessed in the past era is primarily due to better non-invasive prenatal tests, rising maternal age, government backing and healthcare regulations, along with the demand for early diagnosis from patients.
The prenatal and newborn genetic testing market is set to experience a significant surge in growth over the coming years, anticipated to expand to a size of $12.07 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 12.3%. This projected growth over the forecasting period can be linked to the enlargement of genetic test panels, a heightened awareness on maternal health, guidelines for prenatal and newborn screening, as well as an intensified focus on rare diseases and pertinent ethical and regulatory aspects. Important upcoming trends for this forecast period comprise non-invasive prenatal testing (NIPT), whole genome sequencing (WGS), and whole exome sequencing. Other trends include the incorporation of artificial intelligence (AI), preimplantation genetic testing (PGT), and direct-to-consumer genetic testing.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13158&type=smp
What Are the Core Market Drivers Propelling Growth in the Prenatal And Newborn Genetic Testing Industry?
The growth and development of the prenatal and newborn genetic testing markets are expected to be spurred by support and initiatives from the government. Such initiatives generally involve programs, policies, projects, or specific actions taken by a government—be it local, regional, or national—to tackle certain issues, meet set objectives, or enhance the well-being of its populace. These initiatives, particularly for prenatal and newborn genetic testing, aid the inhabitants of the nation by assisting in the detection of genetic abnormalities or conditions in fetuses during pregnancy or in newborns shortly after they are born. Take for example in June 2022, the Australian government committed $1.3 million per year to the New South Wales (NSW) newborn screening initiative which gives free severe combined immunodeficiency (SCID) and spinal muscular atrophy (SMA) tests, covering newborn genetic testing and screening, to every freshly born baby in the state. These screening tests are estimated to benefit around 100,000 infants a year, potentially saving the lives of about 13 newborns who may be susceptible to these genetic anomalies. As such, the support and initiatives provided by governments for prenatal testing and newborn genetic screening are significant driving forces for the prenatal and newborn genetic testing markets.
How Is the Prenatal And Newborn Genetic Testing Market Segmented?
The prenatal and newborn genetic testingmarket covered in this report is segmented –
1) By Product Type: Consumables; Instruments
2) By Screening: Non-Invasive Prenatal Testing; Chronic Villus Sampling; Amniocentesis; Maternal Serum Screening; Other Screenings
3) By Disease: Down Syndrome; Phenylketonuria; Cystic Fibrosis; Sickle Cell Anemia
4) By End User: Hospital; Maternity And Specialty Clinics; Diagnostic Centers
Subsegments:
1) By Consumables: Reagents And Assays; Sample Collection Kits; Test Kits
2) By Instruments: Polymerase Chain Reaction (PCR) Machines; Sequencers; Microarray Analyzers
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=13158&type=smp
Which Regions Are Driving the Next Phase of the Prenatal And Newborn Genetic Testing Market Growth?
North America was the largest region in the prenatal and newborn genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prenatal and newborn genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Key Market Trends and Innovations Are Shaping the Future of the Prenatal And Newborn Genetic Testing Industry?
Significant firms in the market of prenatal and newborn genetic testing are concentrating on the creation of groundbreaking screening tests. These include noninvasive prenatal screening tests that are both affordable and accessible, offering trustworthy services to their clientele. Noninvasive prenatal screening (NIPS), also known as noninvasive prenatal testing (NIPT), is a top-tier and harmless method of genetic screening, carried out during pregnancy to gauge the possibility of certain fetal chromosomal irregularities. For example, in November 2022, Juno Diagnostics Inc., a healthcare technology firm based in the US, introduced Juno Hazel. It is a noninvasive prenatal screening test that identifies chromosomal deviations and offers clinical context. The test employs a sample collection kit, hence no need for phlebotomy, thus enhancing its accessibility. The organization envisions providing educational materials and tailoring genetic counseling support through collaborations with physicians and genetic counselors.
View the full report here:
How Is the Prenatal And Newborn Genetic Testing Market Defined and What Are Its Core Parameters?
Prenatal and newborn genetic testing refers to the medical procedures and screenings conducted during pregnancy and after birth to assess the genetic health and risk factors of both the developing fetus and the newborn baby. These tests are performed to detect and identify genetic disorders, congenital conditions, or hereditary diseases that may affect the child’s health or development.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13158
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model